T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 7,234 | 6,980 | 7,428 | 6,694 | 6,956 |
| Cost of Goods | 6,205 | 5,362 | 4,720 | 4,831 | 5,790 |
| Gross Profit | 1,029 | 1,618 | 2,708 | 1,863 | 1,166 |
| Operating Expenses | 16,091 | 12,259 | 15,640 | 13,474 | 11,658 |
| Operating Income | -14,857 | -10,279 | -12,212 | -10,780 | -9,702 |
| Interest Expense | 1,650 | 2,783 | 1,919 | 1,881 | 1,013 |
| Other Income | 12 | 918 | 169 | 186 | 55 |
| Pre-tax Income | -16,495 | -12,144 | -13,962 | -12,475 | -10,660 |
| Net Income Continuous | -16,495 | -12,144 | -13,962 | -12,475 | -10,660 |
| Net Income | $-16,495 | $-12,144 | $-13,962 | $-12,475 | $-10,660 |
| EPS Basic Total Ops | -486.00 | -379.00 | -421.00 | -400.00 | -350.00 |
| EPS Basic Continuous Ops | -485.56 | -366.68 | -420.84 | -402.72 | -359.57 |
| EPS Diluted Total Ops | -486.00 | -379.00 | -421.00 | -400.00 | -350.00 |
| EPS Diluted Continuous Ops | -485.56 | -366.68 | -420.84 | -402.72 | -359.57 |
| EBITDA(a) | $-14,571 | $-9,685 | $-11,590 | $-10,155 | $-8,853 |